本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Assertio Holdings, Inc.

0.6104
-0.0107-1.72%
盤後0.63700.0266+4.36%19:23 EDT
成交量:29.55萬
成交額:18.09萬
市值:5,845.99萬
市盈率:-2.65
高:0.6350
開:0.6200
低:0.6011
收:0.6211
資料載入中...

公司資料

公司名字:
Assertio Holdings, Inc.
交易所:
NASDAQ
成立時間:
2020
員工人數:
58
公司地址:
100 South Saunders Road,Suite 300,Lake Forest,Illinois,United States
郵編:
60045
電話:
傳真:
510 744 8001
簡介:
Assertio Holdings, Inc.是一家領先的多元化,商業製藥公司,專註於為需要的患者提供增強治療選擇的獨特產品。2020年5月19日,Assertio根據合併協議和計劃實施了Assertio重組。Assertio Therapeutics是Assertio Holdings的全資子公司。

董事

名稱
職位
Arthur J. Higgins
Director,President and Chief Executive Officer
James P. Fogarty
Chairman
James L. Tyree
董事
Karen A. Dawes
董事
Louis J. Lavigne, Jr.
董事
Peter D. Staple
董事
Robert G. Savage
董事

股東

名稱
職位
Arthur J. Higgins
Director,President and Chief Executive Officer
August J. Moretti
Chief Financial Officer and Senior Vice President
Matthew M. Gosling
Senior Vice President and General Counsel
Peter W. Schineller
Senior Vice President, Sales
Sharon D. Larkin
Senior Vice President, Human Resources
Srinivas G. Rao
Senior Vice President and Chief Medical Officer
Thadd M. Vargas
Senior Vice President, Business Development